EcoDrugPlus

Melanocortin 4 Receptor

Ensembl ID : ENSMSIG00000020479
Gene Symbol: MC4R
1 Cross references
136 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSMSIG00000027091
Gene Symbol: MTNR1A
1 Cross references
220 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSMSIG00000015621
Gene Symbol: MTNR1B
1 Cross references
122 Possible Orthologues:

Membrane Metallo Endopeptidase

Ensembl ID : ENSMSIG00000029325
Gene Symbol: MME
1 Cross references
251 Possible Orthologues:

Met Proto-Oncogene

Ensembl ID : ENSMSIG00000020011
Gene Symbol: MET
1 Cross references
226 Possible Orthologues:

Methionine Aminopeptidase 2

Ensembl ID : ENSMSIG00000016737
Gene Symbol: METAP2
1 Cross references
171 Possible Orthologues:

Microtubule-Associated Protein Tau

Ensembl ID : ENSMSIG00000027249
Gene Symbol: MAPT
1 Cross references
270 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSMSIG00000017684
Gene Symbol: MAPK1
1 Cross references
228 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSMSIG00000000530
Gene Symbol: MAPK10
1 Cross references
162 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSMSIG00000021771
Gene Symbol: MAPK11
1 Cross references
215 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSMSIG00000009527
Gene Symbol: MAPK14
1 Cross references
296 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSMSIG00000015568
Gene Symbol: MAPK3
1 Cross references
213 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).